IP Library Granted Patent US 8,007,527
Granted Patent B2
US 8,007,527 · App. 12/633,246 · Granted Aug 30, 2011

Stent with dual support structure

Assignee: ev3 Peripheral, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,007,527
App. No.
12/633,246
Granted
Aug 30, 2011
Kind
B2
Abstract

A intraluminal stent comprises a reticulated tube having an un-deployed diameter and expandable to an enlarged diameter. The tube includes a structural beam extending between first and second ends. The structural beam changes from a first geometry to a second geometry when the tube changes from the un-deployed diameter to the enlarged diameter. The structural beam includes first and second longitudinal elements each extending at least partially between the first and second ends and with a spacing between the first and second elements. Each of said first and second elements changes from the first geometry to the second geometry when the tube changes from the un-deployed diameter to the enlarged diameter for the spacing to remain substantially unchanged as the tube changes from the un-deployed diameter to the enlarged diameter.

Claims (31)

1. A stent comprising:

a stent body expandable between an undeployed orientation and a deployed orientation, the stent body extending along a longitudinal axis,

the stent body including

a cell defining portion that defines an open cell, the cell defining portion including axially spaced-apart first and second segments, the segments each extending about a circumference of the stent body in an undulating pattern that includes a plurality of peaks and valleys, and the cell defining portion including at least two sets of opposing, non-connected valleys;

a pair of first connection locations positioned on circumferentially opposite sides of the cell defining portion for connecting the cell defining portion to circumferentially adjacent cell defining portions; and

a pair of second connection locations positioned on axially opposite sides of the cell defining portion for connecting the cell defining portion to axially adjacent cell defining portions,

wherein each of the first and second segments comprises first and second spaced-apart elements extending from one of the first connection locations to one of the second connection locations and defining said undulating pattern.

2. The stent of claim 1 , wherein the first and second longitudinal segments are configured such that the spacing between the first and second spaced-apart elements remains substantially unchanged as the stent body is expanded from the un-deployed orientation to the deployed orientation.

3. The stent of claim 1 , further comprising a plurality of cells.

4. The stent of claim 3 , wherein the cells are substantially identical.

5. The stent of claim 3 , wherein the cells assume a diamond shape as the stent expands form the un-deployed orientation to the deployed orientation.

6. The stent of claim 1 , wherein the first and second spaced-apart elements are substantially parallel to one another in the un-deployed orientation and remain substantially parallel as the stent expands from the un-deployed orientation to the deployed orientation.

7. The stent of claim 1 , wherein the stent is a balloon expandable stent.

8. The stent of claim 1 , wherein the stent is made of a shape memory material.

9. The stent of claim 8 , wherein the shape memory material is nitinol.

10. A stent comprising:

a stent body expandable between an undeployed orientation and a deployed orientation;

the stent body having cell defining portions with opposing surfaces defining an open cell bounded by the cell defining portions, the cell having a major axis and a minor axis, the minor axis being substantially parallel to a longitudinal axis of the stent body;

the cell defining portions including first and second longitudinal segments each of which includes:

a longitudinal axis extending substantially parallel to the cell major axis, the longitudinal axes being positioned on opposite sides of the cell major axis; and

an undulating pattern that defines a plurality of peaks and valleys spaced outwardly and inwardly, respectively, from the longitudinal axes; the first and second longitudinal segments being interconnected at opposite ends thereof;

the stent body further including first and second longitudinal connection locations at interconnection points of the interconnected first and second longitudinal segments for connection of the cell to first and second longitudinally adjacent cells, respectively, and first and second transverse connection locations on the first and second longitudinal segments, respectively, for connection of the cell to first and second transversely adjacent cells, respectively; and

each of the first and second longitudinal segments comprises first and second spaced-apart elements extending from one of the first and second longitudinal connection locations to one of the first and second connection locations and defining said undulating pattern.

11. The stent of claim 10 , wherein the first and second longitudinal segments are configured such that the spacing between the first and second spaced-apart elements remains substantially unchanged as the stent body is expanded from the un-deployed orientation to the deployed orientation.

12. The stent of claim 10 , further comprising a plurality of cells.

13. The stent of claim 12 , wherein the cells are substantially identical.

14. The stent of claim 12 , wherein the cells assume a diamond shape as the stent expands form the un-deployed orientation to the deployed orientation.

15. The stent of claim 10 , wherein the first and second spaced-apart segments are substantially parallel segments and remain substantially parallel as the stent expands from the un-deployed orientation to the deployed orientation.

16. The stent of claim 10 , wherein the stent is a balloon expandable stent.

17. The stent of claim 10 , wherein the stent is made of a shape memory material.

18. The stent of claim 17 , wherein the shape memory material is nitinol.

Assignments (4)
MERGER Recorded Oct 7, 2014
From: EV3 PERIPHERAL, INC.
To: EV3 INC.
Reel/Frame 033899/0313 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2014
From: EV3 LLC
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 033899/0388 →
CHANGE OF NAME Recorded Oct 7, 2014
From: EV3 INC.
To: EV3 LLC
Reel/Frame 033899/0992 →
CHANGE OF NAME Recorded Oct 7, 2014
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 033900/0014 →
Continuity (6)
Continuation 11042316 · Jan 24, 2005
Continuation 10353353 · Jan 28, 2003
Continuation 09545246 · Apr 7, 2000
Continuation 09069347 · Apr 29, 1998
Continuation In Part 09049486 · Mar 27, 1998
Related Publication 20100087912A1 · Apr 8, 2010